|
(R)-MG-132
|
|
1211877-36-9
|
|
CCT137690
|
|
1095382-05-0
|
|
AF-353
|
|
865305-30-2
|
|
BIO-1211
|
|
187735-94-0
|
|
N-Fmoc-4-(tert-butoxycarbonylmethoxy)-L-phenylalanine
|
|
181951-92-8
|
|
AG-1517
|
|
153436-54-5
|
|
BGP-15
|
|
66611-37-8
|
|
VX-765 (Belnacasan)
|
|
273404-37-8
|
|
Beloranib
|
|
251111-30-5
|
|
GSK1838705A
|
|
1116235-97-2
|
|
SCH 900776 (MK-8776)
|
|
891494-63-6
|
|
GANT61
|
|
500579-04-4
|
|
Ezatiostat
|
|
168682-53-9
|
|
HDAC inhibitor
|
|
660847-06-3
|
|
Guanosine-5'-triphosphate disodium salt
|
|
56001-37-7
|
|
Mirodenafil dihydrochloride
|
|
862189-96-6
|
|
GW2580
|
|
870483-87-7
|
|
Tuberstemonine
|
|
|
|
TC-A-2317 HCl
|
|
1245907-03-2
|
|
BMS-5
|
|
1338247-35-0
|
|
AT 56
|
|
162640-98-4
|
|
KH7
|
|
330676-02-3
|
|
NVP DPP 728 dihydrochloride
|
|
247016-69-9
|
|
CSRM617 Hydrochloride
|
|
787504-88-5
|
|
Mivotilate
|
|
130112-42-4
|
|
Ranirestat
|
|
147254-64-6
|
|
Dorsomorphin 2HCl
|
|
1219168-18-9
|
|
RO4987655
|
|
874101-00-5
|
|
Pungiolide A
|
|
130430-97-6
|
|
TS-011
|
|
339071-18-0
|
|
Teduglutide
|
|
197922-42-2
|
|
U0126-EtOH
|
|
1173097-76-1
|
|
Balapiravir (R1626)
|
|
690270-29-2
|
|
Avatrombopag
|
|
570406-98-3
|
|
MGCD-265 analog
|
|
875337-44-3
|
|
ADX-47273
|
|
851881-60-2
|
|
IRAK inhibitor 4
|
|
1012104-68-5
|
|
PTH (7-84) Human
|
|
|
|
Alda 1
|
|
349438-38-6
|
|
TAK-779
|
|
229005-80-5
|
|
DiZPK
|
|
1337883-32-5
|
|
MK-2894
|
|
1006036-87-8
|
|
Haloperidol D4
|
|
1189986-59-1
|
|
Dabigatran ethyl ester
|
|
429658-95-7
|
|
Crovatin
|
|
142409-09-4
|
|
Araloside X
|
|
344911-90-6
|
|
SMER-3
|
|
67200-34-4
|
|
CAY10505
|
|
1218777-13-9
|
|
CMK
|
|
821794-90-5
|
|
Cytochrome P450 14a-demethylase inhibitor 1L
|
|
1155361-10-6
|
|
BMP6 Human
|
|
|
|
KW-2449
|
|
1000669-72-6
|
|
Mulberroside C
|
|
102841-43-0
|
|
L,L-Dityrosine hydrochloride
|
|
221308-01-6
|
|
AC-264613
|
|
1051487-82-1
|
|
TCS2314
|
|
317353-73-4
|
|
Garcinone D
|
|
107390-08-9
|
|
MCL0020
|
|
475498-26-1
|
|
Pyr3
|
|
1160514-60-2
|
|
Vilazodone Hydrochloride
|
|
163521-08-2
|
|
Fmoc-Asp(OAll)-OH
|
|
146982-24-3
|
|
FGF 19 Human
|
|
|
|
CPA inhibitor
|
|
223532-02-3
|
|
WAY 163909
|
|
428868-32-0
|
|
KW-2478
|
|
819812-04-9
|
|
Indacaterol maleate
|
|
753498-25-8
|
|
AG14361
|
|
328543-09-5
|
|
(S)-Methyl 2-amino-3-(3-hydroxyphenyl)propanoate hydrochloride
|
|
34260-72-5
|
|
Tepotinib (EMD-1214063)
|
|
1100598-32-0
|
|
BMS-707035
|
|
729607-74-3
|
|
MAC13772
|
|
4871-40-3
|
|
BIX02188
|
|
334949-59-6
|
|
LY2886721
|
|
1262036-50-9
|
|
PS 48
|
|
1180676-32-7
|
|
(+)-JQ1
|
|
1268524-70-4
|
|
Bis-PEG4-acid
|
|
31127-85-2
|
|
N6-Diazo-L-Fmoc-lysine
|
|
159610-89-6
|
|
NVP-ACC789
|
|
300842-64-2
|
|
Glycitein
|
|
40957-83-3
|
|
YK 4-279
|
|
1037184-44-3
|
|
Glyoxalase I inhibitor
|
|
221174-33-0
|
|
MBX-2982
|
|
1037792-44-1
|
|
MG149
|
|
1243583-85-8
|
|
gamma-secretase modulator 1
|
|
1172637-87-4
|
|
Ralimetinib
|
|
862505-00-8
|
|
ROCK inhibitor
|
|
867017-68-3
|
|
VU591 hydrochloride
|
|
1315380-70-1
|
|
NVP-BHG712
|
|
940310-85-0
|
|
Vortioxetine (Lu AA21004) hydrobromide
|
|
960203-27-4
|
|
CP-673451
|
|
343787-29-1
|
|
MK-2206 2HCl
|
|
1032350-13-2
|
|
MMK1
|
|
271246-66-3
|
|
XL184 free base (Cabozantinib)
|
|
849217-68-1
|
|
Begacestat (GSI-953)
|
|
769169-27-9
|
|
AZD6482
|
|
1173900-33-8
|
|
AR-M 1000390 hydrochloride
|
|
209808-47-9
|
|
BINA
|
|
866823-73-6
|
|
MK-3697
|
|
1224846-01-8
|
|
FR 180204
|
|
865362-74-9
|
|
Forsythin
|
|
487-41-2
|